Generated: May 29, 2017
|Title:||Ocular hypotensive agents|
|Abstract:||The present invention relates to ocular hypotensive agents which contains 13,14-dihydro-15-keto-prostagrandins, which shows no transient ocular hypertensive response that PGs usually show.|
|Inventor(s):||Ueno; Ryuzo (Nishinomiya), Ueno; Ryuji (Nishinomiya), Oda; Tomio (Itami, JP)|
|Assignee:||K.K. Ueno Seiyaku Oyo Kenkyujo (Osaka, JP)|
1. A topical ocular hypotensive composition comprising an amount of a 13,14-dihydro-15-keto-20-ethyl-PGF.sub.2.alpha. isopropyl ester effective as an ocular hypotensive agent and a
pharmaceutically acceptable carrier.
2. The ocular hypotensive composition of claim 1, wherein the 13,14-dihydro-15-keto-20-ethyl-PGE.sub.2.alpha. isopropyl ester is present in an amount effective for treating glaucoma.
3. The ocular hypotensive composition of claim 1 in the form of a topical eye drop.